A novel gas chromatography method was developed using automatic injections to identify and quantify the amount of residual solvents or analytes in samples of fluorine-18 and carbon-11 radiopharmaceuticals. This approach evaluates seven analytes in less than 5 versus 13 min of acquisition time. The method additionally includes a 3 min bakeout to aid in the removal and carry-over of higher-boiling impurities. Chromatographic parameters such as column temperature, hold time, column pressure, flow rate, and split ratios were adjusted and optimized to analyze radioactive drug samples containing analytes which include methanol, ethanol, acetone, acetonitrile, triethylamine, N,N-dimethylformamide, and dimethyl sulfoxide. The relative standard deviation for each solvent was determined to be no greater than 1.6%. The method limit of detection (LOD) and limit of quantification (LOQ) were between 0.053 and 0.163 and 0.000 (5.791 × 10−6) and 0.520 mg/mL, respectively. This GC technique, using flame ionization detection (FID), was validated and is currently employed for the routine quality control of all approved IND and RDRC PET radiopharmaceuticals at our center.
A successful positron emission tomography imaging program involving carbon-11 radiotracers demands fast, efficient, and reliable synthesis methods, requiring an on-site cyclotron and radiochemistry group, as well as clinical staff trained to operate under the unique constraints of the carbon-11 radionuclide. This study examines the merits and advantages of a captive solvent 'loop method' of radiolabeling four tracers with the carbon-11 radionuclide, producing the radioligands [11C]ER-176, [11C]MRB, [11C]mHED, and [11C]PiB. The 'loop method' is compared against the traditional reactor-based method of carbon-11 methylation in the course of synthesizing the same radiotracers on the identical automated platform. Further, a complete overview of the clinical research preparation of the [11C]ER-176 radiotracer is presented. As demonstrated by the production of [11C]ER-176, the captive solvent 'loop method' of heterogeneous alkylation proved to be more efficient, with excellent radiochemical purity (99.6 ± 0.6%, n = 25), higher and more consistent radiochemical yield (end of synthesis (EOS) = 5.4 ± 2.2 GBq, n = 25) compared to the reactor method (EOS = 1.6 ± 0.5 GBq, n = 6), increased molar activity (loop method = 194 ± 66 GBq/µmol, n = 25; reactor method = 132 ± 78 GBq/µmol, n = 6), along with an average 5 min shorter reaction sequence.
Incorporation of carbon-11 radiotracers for positron emission tomography (PET) imaging requires close coordination between cyclotron operation, radiochemistry production, quality control, and clinical administration. A persistent challenge exists is the minimization of the carbon-12 isotopologue mass of the radiotracer, which reduces molar activity and can compromise PET image quality. This challenge can be particularly acute at facilities where cyclotron operation and carbon-11 radiochemistry are realized by separate organizations with distinct operational priorities. Here, we describe how the Radiochemistry Group at New York University Grossman School of Medicine and Siemens Healthineers have developed an integrated operational framework for consistent, high-quality carbon-11 production within an academic–industry partnership. Cyclotron target maintenance and conditioning protocols, remote chemistry module maintenance schedules, a validated radio-HPLC method (UV LOD = 0.9 µg/mL, UV LOQ = 3.0 µg/mL) for trending methyl iodide isotopologue mass, and structured inter-team communication protocols are presented in this manuscript. Quality analysis demonstrates molar activities consistently exceeding the recommended minimum of 40 GBq/µmol for reversibly binding radiotracers used in human PET studies. This work is intended as a practical resource for radiochemists, cyclotron engineers, and facility managers working to establish or improve institutional carbon-11 programs.